Literature DB >> 24811020

A multifaceted intervention for patients with anaphylaxis increases epinephrine use in adult emergency department.

Veena Manivannan1, Erik P Hess2, Venkatesh R Bellamkonda1, David M Nestler1, M Fernanda Bellolio1, John B Hagan3, Kharmene L Sunga1, Wyatt W Decker1, James T C Li3, Lori N Scanlan-Hanson1, Samuel C Vukov1, Ronna L Campbell4.   

Abstract

BACKGROUND: Studies have documented inconsistent emergency anaphylaxis care and low compliance with published guidelines.
OBJECTIVE: To evaluate anaphylaxis management before and after implementation of an emergency department (ED) anaphylaxis order set and introduction of epinephrine autoinjectors, and to measure the effect on anaphylaxis guideline adherence.
METHODS: A cohort study was conducted from April 29, 2008, to August 9, 2012. Adult patients in the ED who were diagnosed with anaphylaxis were included. ED management, disposition, self-injectable epinephrine prescriptions, allergy follow-up, and incidence of biphasic reactions were evaluated.
RESULTS: The study included 202 patients. The median age of the patients was 45.3 years (interquartile range, 31.3-56.4 years); 139 (69%) were women. Patients who presented after order set implementation were more likely to be treated with epinephrine (51% vs 33%; odds ratio [OR] 2.05 [95% CI, 1.04-4.04]) and admitted to the ED observation unit (65% vs 44%; OR 2.38 [95% CI, 1.23-4.60]), and less likely to be dismissed home directly from ED (16% vs 29%, OR 0.47 [95% CI, 0.22-1.00]). Eleven patients (5%) had a biphasic reaction. Of these, 5 (46%) had the biphasic reaction in the ED observation unit; 1 patient was admitted to the intensive care unit. Six patients (55%) had reactions within 6 hours of initial symptom resolution, of whom 2 were admitted to the intensive care unit.
CONCLUSIONS: Significantly higher proportions of patients with anaphylaxis received epinephrine and were admitted to the ED observation unit after introduction of epinephrine autoinjectors and order set implementation. Slightly more than half of the biphasic reactions occurred within the recommended observation time of 4 to 6 hours. Analysis of these data suggests that the multifaceted approach to changing anaphylaxis management described here improved guideline adherence.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaphylaxis; Clinical decision support; Emergency department; Order set; Self-injectable epinephrine

Mesh:

Substances:

Year:  2014        PMID: 24811020      PMCID: PMC4017251          DOI: 10.1016/j.jaip.2013.11.009

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  21 in total

1.  Further fatalities caused by anaphylactic reactions to food, 2001-2006.

Authors:  S Allan Bock; Anne Muñoz-Furlong; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2007-02-15       Impact factor: 10.793

2.  Fatal anaphylaxis: postmortem findings and associated comorbid diseases.

Authors:  Paul A Greenberger; Brian D Rotskoff; Barry Lifschultz
Journal:  Ann Allergy Asthma Immunol       Date:  2007-03       Impact factor: 6.347

3.  Fatalities due to anaphylactic reactions to foods.

Authors:  S A Bock; A Muñoz-Furlong; H A Sampson
Journal:  J Allergy Clin Immunol       Date:  2001-01       Impact factor: 10.793

4.  Increasing cost of epinephrine autoinjectors.

Authors:  Emma Westermann-Clark; David J Fitzhugh; Richard F Lockey
Journal:  J Allergy Clin Immunol       Date:  2012-07-22       Impact factor: 10.793

5.  World Allergy Organization anaphylaxis guidelines: summary.

Authors:  F Estelle R Simons; Ledit R F Ardusso; M Beatrice Bilò; Yehia M El-Gamal; Dennis K Ledford; Johannes Ring; Mario Sanchez-Borges; Gian Enrico Senna; Aziz Sheikh; Bernard Y Thong
Journal:  J Allergy Clin Immunol       Date:  2011-03       Impact factor: 10.793

6.  Multicenter study of emergency department visits for food allergies.

Authors:  Sunday Clark; S Allan Bock; Theodore J Gaeta; Barry E Brenner; Rita K Cydulka; Carlos A Camargo
Journal:  J Allergy Clin Immunol       Date:  2004-02       Impact factor: 10.793

Review 7.  The post-anaphylaxis dilemma: how long is long enough to observe a patient after resolution of symptoms?

Authors:  Stephen F Kemp
Journal:  Curr Allergy Asthma Rep       Date:  2008-03       Impact factor: 4.806

8.  Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.

Authors:  Hugh A Sampson; Anne Muñoz-Furlong; Ronna L Campbell; N Franklin Adkinson; S Allan Bock; Amy Branum; Simon G A Brown; Carlos A Camargo; Rita Cydulka; Stephen J Galli; Jane Gidudu; Rebecca S Gruchalla; Allen D Harlor; David L Hepner; Lawrence M Lewis; Phillip L Lieberman; Dean D Metcalfe; Robert O'Connor; Antonella Muraro; Amanda Rudman; Cara Schmitt; Debra Scherrer; F Estelle R Simons; Stephen Thomas; Joseph P Wood; Wyatt W Decker
Journal:  J Allergy Clin Immunol       Date:  2006-02       Impact factor: 10.793

9.  Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis.

Authors:  Ronna L Campbell; Anuradha Luke; Amy L Weaver; Jennifer L St Sauver; Eric J Bergstralh; James T Li; Veena Manivannan; Wyatt W Decker
Journal:  Ann Allergy Asthma Immunol       Date:  2008-12       Impact factor: 6.347

10.  Confusion about epinephrine dosing leading to iatrogenic overdose: a life-threatening problem with a potential solution.

Authors:  Manreet Kanwar; Charlene B Irvin; John J Frank; Kathryn Weber; Howard Rosman
Journal:  Ann Emerg Med       Date:  2010-01-19       Impact factor: 5.721

View more
  6 in total

1.  Autoinjectors Preferred for Intramuscular Epinephrine in Anaphylaxis and Allergic Reactions.

Authors:  Ronna L Campbell; M Fernanda Bellolio; Megan S Motosue; Kharmene L Sunga; Christine M Lohse; Maria I Rudis
Journal:  West J Emerg Med       Date:  2016-10-07

Review 2.  Diagnosis and treatment of anaphylaxis: there is an urgent needs to implement the use of guidelines.

Authors:  Maria Luiza Kraft Köhler Ribeiro; Herberto José Chong Neto; Nelson Augusto Rosario Filho
Journal:  Einstein (Sao Paulo)       Date:  2017-12-07

Review 3.  Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities.

Authors:  Benjamin T Prince; Irene Mikhail; David R Stukus
Journal:  J Asthma Allergy       Date:  2018-06-20

4.  2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines.

Authors:  F Estelle R Simons; Motohiro Ebisawa; Mario Sanchez-Borges; Bernard Y Thong; Margitta Worm; Luciana Kase Tanno; Richard F Lockey; Yehia M El-Gamal; Simon Ga Brown; Hae-Sim Park; Aziz Sheikh
Journal:  World Allergy Organ J       Date:  2015-10-28       Impact factor: 4.084

5.  Should adrenaline be used in patients with hemodynamically stable anaphylaxis? Incident case control study nested within a retrospective cohort study.

Authors:  Byuk Sung Ko; Ji Yeon Kim; Dong-Woo Seo; Won Young Kim; Jae Ho Lee; Aziz Sheikh; David W Bates
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

6.  Anaphylaxis-related Malpractice Lawsuits.

Authors:  Rachel A Lindor; Erika M McMahon; Joseph P Wood; Annie T Sadosty; Eric T Boie; Ronna L Campbell
Journal:  West J Emerg Med       Date:  2018-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.